background
purpos
studi
determin
incid
signific
hypouricemia
patient
sever
acut
respiratori
syndrom
sar
pulmonari
lesion
patient
sar
thought
result
proinflammatori
cytokin
dysregul
acut
renal
failur
report
patient
sar
whether
cytokin
injur
renal
tubul
unknown
method
sixti
patient
diagnos
sar
taiwan
april
studi
patient
identifi
hypouricem
serum
uric
acid
ua
level
less
mgdl
moll
within
day
fever
onset
urin
ua
creatinin
level
avail
patient
serum
cytokin
tumor
necrosi
measur
patient
result
sixteen
patient
hypouricemia
ua
mgdl
moll
differ
age
sex
symptom
vital
sign
hemogram
biochemistri
data
exist
hypouricem
normouricem
group
fraction
excret
fe
ua
fe
ua
hypouricem
patient
significantli
greater
normouricem
patient
p
adjust
age
sex
high
fe
ua
significantli
associ
lowest
blood
oxygen
p
r
number
catastroph
outcom
endotrach
intub
andor
death
adjust
older
age
sex
show
hypourem
patient
odd
ratio
confid
interv
p
kaplanmei
curv
catastroph
outcomefre
result
show
signific
differ
patient
normouricemia
hypouricemia
p
serum
level
correl
significantli
fe
ua
p
r
invers
serum
ua
level
p
r
neither
level
show
correl
conclus
one
fourth
patient
sar
develop
hypouricemia
might
result
defect
renal
ua
handl
associ
high
serum
level
renal
hypouricemia
omin
sign
patient
sar
j
kidney
di
p
atient
sever
acut
respiratori
syndrom
sar
caus
new
coronaviru
cov
present
fever
respiratori
symptom
although
viru
found
urin
patient
renal
function
usual
preserv
acut
renal
failur
arf
uncommon
caus
arf
patient
sar
studi
multifactori
eg
infect
rhabdomyolysi
antivir
agent
hypoxemia
howev
observ
elev
serum
creatinin
level
patient
arf
preced
increas
serum
cytokin
level
indic
proinflammatori
cytokinerel
renal
lesion
may
import
role
direct
indirect
associ
viral
infect
human
renal
diseas
note
year
sever
pathogen
mechan
postul
contribut
renal
diseas
associ
viral
infect
virusrel
renal
diseas
mainli
involv
glomeruli
howev
lesion
renal
tubul
interstitium
report
infrequ
show
interstiti
infiltr
inflammatori
cell
renal
histolog
specimen
obtain
necropsi
patient
sar
complic
arf
take
observ
togeth
specul
signific
elev
proinflammatori
cytokin
level
may
pivot
role
renal
injuri
patient
sar
proxim
tubular
injuri
observ
commonli
patient
interstiti
inflamm
clinic
manifest
defect
organ
acid
electrolyt
transport
hypouricemia
caus
uricosuria
shown
patient
acut
chronic
tubulointerstiti
nephriti
rare
report
patient
system
infect
without
frank
renal
diseas
although
mechan
elucid
renal
hypouricemia
patient
system
infect
shown
factor
poor
prognosi
present
studi
examin
preval
hypouricemia
patient
sar
signific
outcom
patient
seventyfour
patient
probabl
sar
admit
hospit
april
may
endem
sar
occur
island
diagnosi
probabl
sar
made
presenc
fever
greater
respiratori
symptom
contact
histori
either
pneumon
patch
chest
film
posit
test
cov
definit
probabl
sar
center
diseas
control
prevent
world
health
organ
seven
patient
exclud
studi
diuret
administ
blood
sampl
anoth
patient
exclud
test
serum
uric
acid
ua
within
day
onset
fever
sarscov
detect
patient
mean
reversetranscriptas
polymeras
chain
reaction
throat
swab
anoth
patient
neg
throat
swab
result
sarscov
seroconvers
detect
mean
immunofluoresc
assay
patient
mean
enzymelink
immunosorb
assay
patient
patient
direct
microbiolog
serolog
evid
sarscov
infect
end
studi
clinic
cours
compat
probabl
sar
clear
relationship
well
exposur
initi
immigr
cluster
later
intrahospit
outbreak
taiwan
diagnosi
sar
patient
confirm
committe
center
diseas
control
taiwan
serum
ua
measur
least
twice
patient
includ
studi
howev
blood
sampl
perform
fix
schedul
data
cluster
period
onset
fever
measur
obtain
period
lowest
level
period
use
analysi
multipl
daili
measur
perform
data
obtain
closest
analyz
hypouricemia
defin
serum
ua
level
within
day
onset
fever
less
mgdl
moll
sd
less
mean
ua
level
measur
hospit
standard
formula
use
calcul
fraction
excret
fe
ua
fe
ua
fe
ua
urin
ua
serum
creatinin
urin
creatinin
serum
ua
hypouricem
patient
fe
ua
greater
defin
inappropri
uricosuria
biochem
paramet
measur
use
toshiba
clinic
chemistri
analyz
toshiba
tochigiken
japan
ua
measur
use
uricas
method
serum
level
tumor
necrosi
interleukin
determin
use
immunometr
assay
immulit
diagnost
product
corp
lo
angel
ca
blood
oxygen
satur
hospit
patient
automat
record
time
everi
day
use
puls
oximetri
agil
andov
lowest
valu
day
renal
excret
ua
studi
use
analysi
result
express
mean
sd
unless
otherwis
specifi
unpair
student
ttest
appli
analyz
continu
data
either
chisquar
test
fisher
exact
test
appli
analyz
categor
data
statist
analys
perform
use
spss
window
version
spss
inc
chicago
il
comparison
data
group
made
use
ttest
random
data
addit
repeat
measur
ua
variabl
hypourem
normourem
patient
analyz
use
analysi
varianc
result
differ
significantli
post
hoc
comparison
perform
use
ttest
pair
data
test
catastroph
outcom
defin
death
need
mechan
ventil
time
discharg
time
catastroph
outcom
examin
use
surviv
analysi
followup
patient
start
fever
onset
end
discharg
data
censor
end
followup
patient
still
hospit
time
discharg
still
aliv
time
death
catastroph
outcom
kaplanmei
productlimit
method
use
estim
surviv
plot
time
event
hypouricemia
normouricemia
group
logrank
test
compar
differ
group
p
less
consid
statist
signific
patient
age
year
women
men
thirtyf
patient
serum
ua
level
measur
day
fever
onset
respect
sixteen
patient
hypouricem
serum
ua
level
mgdl
moll
remaind
serum
ua
level
mgdl
moll
shown
fig
period
hypouricem
patient
lower
serum
ua
level
normouricem
patient
hypouricem
patient
lowest
serum
ua
level
observ
day
onset
fever
p
compar
day
return
baselin
day
fever
onset
p
compar
day
convers
serum
ua
level
normouricem
patient
unchang
time
p
eleven
hypouricem
patient
serum
ua
level
return
normal
ua
mgdl
fever
onset
day
four
patient
remain
hypouricem
day
patient
without
ua
data
day
patient
persist
hypouricemia
show
graver
prognosi
patient
correct
hypouricemia
intub
dead
p
differ
age
sex
symptom
ie
sore
throat
runni
nose
cough
myalgia
diarrhea
vital
sign
admiss
group
tabl
preval
hypertens
diabet
ischem
heart
diseas
group
tabl
hemogram
biochem
paramet
measur
admiss
list
tabl
differ
group
white
blood
cell
count
hematocrit
valu
platelet
count
level
urea
nitrogen
serum
creatinin
creatin
kinas
electrolyt
fortythre
patient
hypouricem
normouricem
urin
sampl
avail
calcul
fe
ua
electrolyt
level
day
fever
onset
fe
ua
hypouricem
group
significantli
greater
normouricem
group
versu
p
hypouricem
patient
inappropri
uricosuria
fe
ua
invers
correl
fig
three
hypouricem
patient
posit
urin
glucos
test
result
detect
multistix
bayer
taiwan
includ
patient
diabet
plasma
glucos
level
greater
mgdl
mmoll
patient
treat
ribavirin
mgd
methylprednisolon
mgkgd
day
depend
patient
condit
intraven
immunoglobulin
gkgd
day
differ
treatment
regimen
group
tabl
logist
regress
analysi
show
signific
correl
serum
ua
level
medic
except
modest
correl
ribavirin
treatment
fe
ua
p
differ
group
durat
fever
hospit
stay
incid
arf
howev
hypouricem
patient
need
endotrach
intub
ventil
support
normouricem
patient
p
tabl
twenti
patient
underw
endotrach
intub
mechan
ventil
fe
ua
greater
patient
undergo
mechan
ventil
p
fig
five
hypouricem
patient
normouricem
patient
die
twentythre
patient
cohort
catastroph
outcom
endotrach
intub
andor
death
convert
blood
urea
nitrogen
mgdl
mmoll
multipli
serum
creatinin
mgdl
moll
multipli
sodium
potassium
meql
mmoll
multipli
calcium
mgdl
mmoll
multipli
phosphat
mgdl
mmoll
multipli
number
catastroph
outcom
adjust
older
age
sex
show
hypourem
patient
odd
ratio
confid
interv
p
kaplanmei
curv
catastroph
outcomefre
result
show
signific
differ
patient
normouricemia
hypouricemia
log
rank
p
fig
fe
ua
correl
peak
creatin
kinas
level
p
r
measur
within
first
day
need
endotrach
intub
support
ventil
p
r
correl
neg
blood
oxygen
satur
p
r
adjust
age
sex
fe
ua
remain
significantli
associ
blood
oxygen
satur
p
r
adjust
r
moreov
fe
ua
greater
patient
need
endotrach
intub
ventil
support
p
fig
serum
level
proinflammatori
cytokin
measur
patient
hypouricem
normouricem
ua
excret
studi
level
correl
significantli
fe
ua
p
r
invers
serum
ua
level
p
r
fig
howev
similar
correl
observ
either
level
studi
one
fourth
patient
sar
hypouricemia
clinic
featur
report
previous
consid
ribavirin
treatment
may
increas
serum
ua
level
incid
hypouricemia
patient
sar
may
underestim
hypouricem
patient
present
studi
inappropri
uricosuria
invers
correl
serum
ua
level
fe
ua
indic
hypouricemia
patient
sar
result
abnorm
increas
ua
excret
sarscov
infect
although
sarscov
could
detect
patient
urin
patient
sar
studi
normal
renal
function
acut
interstiti
nephriti
associ
variou
viral
infect
report
sarscov
infect
report
necropsi
case
patient
sar
arf
find
glomerular
tubular
lesion
sever
diseas
factor
may
caus
renal
hypouricemia
eg
obstruct
jaundic
solid
hematolog
neoplasia
diabet
mellitu
drug
affect
urat
homeostasi
renal
hypouricemia
associ
infect
report
infrequ
although
substanti
proport
patient
acquir
immunodefici
syndrom
present
renal
hypouricemia
cotrimoxazol
thought
contributori
factor
caus
renal
hypouricemia
patient
system
infect
known
four
complementari
dna
express
protein
transport
urat
recent
clone
mutat
defect
identifi
patient
renal
hypouricemia
mechan
urat
transport
regul
fulli
understood
although
proinflammatori
cytokin
data
obtain
small
proport
patient
sar
interest
serum
level
correl
significantli
fe
ua
shown
proinflammatori
cytokin
influenc
ua
excret
modul
activ
channel
transport
variou
mechan
knowledg
effect
cytokin
urat
transport
investig
previou
report
indic
mean
time
immunoglobulin
g
seroconvers
sarscov
occur
day
accompani
declin
serum
level
proinflammatori
cytokin
convalesc
stage
studi
show
lowest
serum
ua
level
occur
day
fever
onset
cytokin
storm
patient
sar
usual
occur
hypouricemia
poor
prognost
indic
patient
intraabdomin
sepsi
radiat
pneumon
patient
acquir
immunodefici
syndrom
infect
central
nervou
system
renal
hypouricemia
also
omin
sign
present
studi
show
hypouricem
patient
sar
poor
outcom
especi
term
respiratori
failur
compar
normouricem
patient
moreov
kaplanmei
curv
catastroph
outcomefre
result
show
signific
differ
patient
normouricemia
hypouricemia
addit
fe
ua
correl
invers
blood
oxygen
ua
main
metabolit
adenosin
triphosph
degrad
increas
ua
excret
observ
patient
respiratori
failur
howev
patient
serum
ua
level
decreas
chang
treatment
implic
increas
ua
product
rather
abnorm
ua
renal
handl
hypox
patient
specul
hypoxia
hypouricemia
patient
sar
indic
sever
sarscov
infect
affect
ventil
ua
excret
vivo
vitro
studi
shown
ua
import
antioxid
contribut
much
freerad
scaveng
human
serum
prospect
random
control
clinic
trial
show
nucleotidesuppl
diet
could
significantli
reduc
complic
shorten
hospit
stay
admiss
intens
care
unit
suggest
serum
ua
possibl
surrog
antioxid
capac
clear
whether
poor
outcom
hypouricem
patient
sar
caus
part
shortag
antioxid
summari
hypouricemia
result
abnorm
renal
urat
handl
rare
patient
sarscov
infect
may
reflect
sever
diseas
predict
poor
patient
outcom
signific
relationship
level
fe
ua
need
investig
